JIN THONG-GYU,CHUNG YO KYUNG,PAIK SANG HOON,PARK YOO CHANG,SEO JINWOOK,CHOI YONG WOON,SON JONG MUN,KIM YONG-CHUL
申请号：
IN409/DELNP/2014
公开号：
IN2014DN00409A
申请日:
2014.01.17
申请国别(地区):
IN
年份:
2016
代理人:
摘要：
Disclosed is a composition comprising recombinant iduronate 2 sulfatase (IDS). The glycosylation pattern and formylglycine content of the IDS composition are different from those of Elaprase and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.
